258 related articles for article (PubMed ID: 16019534)
1. Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia.
Kim JG; Sohn SK; Kim DH; Baek JH; Lee NY; Suh JS; Chae SC; Lee KS; Lee KB
Leuk Lymphoma; 2005 Jun; 46(6):885-91. PubMed ID: 16019534
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.
Zhelyazkova AG; Tonchev AB; Kolova P; Ivanova L; Gercheva L
Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087
[TBL] [Abstract][Full Text] [Related]
3. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.
Verstovsek S; Kantarjian H; Estey E; Aguayo A; Giles FJ; Manshouri T; Koller C; Estrov Z; Freireich E; Keating M; Albitar M
Leukemia; 2001 Aug; 15(8):1165-70. PubMed ID: 11480557
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
Aguayo A; Kantarjian H; Manshouri T; Gidel C; Estey E; Thomas D; Koller C; Estrov Z; O'Brien S; Keating M; Freireich E; Albitar M
Blood; 2000 Sep; 96(6):2240-5. PubMed ID: 10979972
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
6. Investigating the role of angiogenesis in systemic lupus erythematosus.
Liu J; Wang X; Yang X; Yan Q; Wang S; Han W
Lupus; 2015 May; 24(6):621-7. PubMed ID: 25359881
[TBL] [Abstract][Full Text] [Related]
7. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase, not vascular endothelial growth factor or basic fibroblast growth factor, positively correlates to bone marrow vascularity in acute myeloid leukemia.
Teng CL; Young JH; Hsu SL; Chou G; Kuo IT; Yu CY; Hwang GY
J Chin Med Assoc; 2006 Nov; 69(11):534-7. PubMed ID: 17116616
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Aref S; Salama O; Shamaa S; El-Refaie M; Mourkos H
Hematology; 2007 Aug; 12(4):319-24. PubMed ID: 17654059
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia.
Hjorth-Hansen H; Seidel C; Lamvik J; Börset M; Sundan A; Waage A
Eur J Haematol; 1999 Feb; 62(2):129-34. PubMed ID: 10052717
[TBL] [Abstract][Full Text] [Related]
12. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia: analysis.
Ishikawa J; Yoshimura M; Matsunashi T; Tominaga N; Teshima H; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Jpn J Clin Oncol; 1991 Jun; 21(3):169-75. PubMed ID: 1719259
[TBL] [Abstract][Full Text] [Related]
13. [Expression of angiogenic factors and their clinical significances in acute myeloid leukemia].
Wang Y; Xiao ZJ; Liu P; Peng Z; Han ZC
Ai Zheng; 2004 Nov; 23(11 Suppl):1423-7. PubMed ID: 15566649
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serum hepatocyte growth factor in clear cell renal cell carcinoma: comparison with serum vascular endothelial growth factor.
Tanimoto S; Fukumori T; El-Moula G; Shiirevnyamba A; Kinouchi S; Koizumi T; Nakanishi R; Yamamoto Y; Taue R; Yamaguchi K; Nakatsuji H; Kishimoto T; Izaki H; Oka N; Takahashi M; Kanayama HO
J Med Invest; 2008 Feb; 55(1-2):106-11. PubMed ID: 18319552
[TBL] [Abstract][Full Text] [Related]
15. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
16. The angioregulatory phenotype of native human acute myelogenous leukemia cells: influence of karyotype, Flt3 abnormalities and differentiation status.
Glenjen N; Hovland R; Wergeland L; Wendelbo Ø; Ernst P; Bruserud Ø
Eur J Haematol; 2003 Sep; 71(3):163-73. PubMed ID: 12930316
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactive calcitonin: a tumor marker for myelogenous leukemias.
Foa P; Ortolani S; Pogliani EM; Iurlo A; Gualdoni A; Maiolo AT; Polli EE
Int J Biol Markers; 1990; 5(1):27-30. PubMed ID: 2230349
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb.
Nemet D; Labar B; Bogdanic V; Skodlar J; Petrovecki M; Mrsic M; Maravic N; Sneller V; Radman I; Kovacevic-Metelko J
Wien Med Wochenschr; 1995; 145(2-3):61-4. PubMed ID: 7762256
[TBL] [Abstract][Full Text] [Related]
19. Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics.
Aref S; Mabed M; Sakrana M; Goda T; El-Sherbiny M
Hematology; 2002 Oct; 7(5):273-9. PubMed ID: 12850814
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern and prognostic implication of SALL4 gene in myeloid leukemias: a case-control study.
Farawela HM; Zawam HM; Al-Wakeel HA; El-Nagdy MH; El-Refaey FA; Abdel-Rahman HA
Scand J Clin Lab Invest; 2019; 79(1-2):65-70. PubMed ID: 30638095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
